Search research articles
Contact Us
Filters
Showing results (811-820 of 1,023) with videos related to
Page
of 103
Sort By:
The American Journal of Medicine
|
January 28, 2010
Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes
Renato D Lopes, Aijing Starr, Carl F Pieper, et al.
Journal of the American College of Cardiology
|
March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
Lars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Circulation
|
November 22, 2019
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial
Frederik Dalgaard, Hillary Mulder, Daniel M Wojdyla, et al.
American Heart Journal
|
November 6, 2018
Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study
Mintu P Turakhia, Manisha Desai, Haley Hedlin, et al.
Annals of Human Genetics
|
October 19, 2006
Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q
S H Shah, W E Kraus, D C Crossman, et al.
Circulation
|
September 10, 2008
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial
Christopher E Buller, Yuling Fu, Kenneth W Mahaffey, et al.
American Heart Journal
|
November 7, 2015
Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure
Shelby D Reed, Matthew P Neilson, Matthew Gardner, et al.
Circulation
|
June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Alvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial
Justin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.
BMC Genetics
|
February 29, 2012
Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5
Daniel K Nolan, Beth Sutton, Carol Haynes, et al.
Page
of 103
Search research articles
Search
Showing results (811-820 of 1,023) with videos related to
Sort By:
Page
of 103
The American Journal of Medicine
|
January 28, 2010
Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes
Renato D Lopes, Aijing Starr, Carl F Pieper, et al.
Journal of the American College of Cardiology
|
March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
Lars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Circulation
|
November 22, 2019
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial
Frederik Dalgaard, Hillary Mulder, Daniel M Wojdyla, et al.
American Heart Journal
|
November 6, 2018
Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study
Mintu P Turakhia, Manisha Desai, Haley Hedlin, et al.
Annals of Human Genetics
|
October 19, 2006
Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q
S H Shah, W E Kraus, D C Crossman, et al.
Circulation
|
September 10, 2008
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial
Christopher E Buller, Yuling Fu, Kenneth W Mahaffey, et al.
American Heart Journal
|
November 7, 2015
Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure
Shelby D Reed, Matthew P Neilson, Matthew Gardner, et al.
Circulation
|
June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Alvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial
Justin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.
BMC Genetics
|
February 29, 2012
Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5
Daniel K Nolan, Beth Sutton, Carol Haynes, et al.
Page
of 103